These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35533965)
1. Co-delivery of Docetaxel and Resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer. Zhang L; Lin Z; Chen Y; Gao D; Wang P; Lin Y; Wang Y; Wang F; Han Y; Yuan H Eur J Pharm Sci; 2022 Jul; 174():106199. PubMed ID: 35533965 [TBL] [Abstract][Full Text] [Related]
2. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma. Jhaveri A; Deshpande P; Pattni B; Torchilin V J Control Release; 2018 May; 277():89-101. PubMed ID: 29522834 [TBL] [Abstract][Full Text] [Related]
3. Rapamycin enhances the susceptibility of both androgen-dependent and -independent prostate carcinoma cells to docetaxel. Liu QJ; Xu XH; Shang DH; Tian Y; Lü WC; Zhang YH Chin Med J (Engl); 2010 Feb; 123(3):356-60. PubMed ID: 20193259 [TBL] [Abstract][Full Text] [Related]
4. Anti-breast cancer activity of resveratrol encapsulated in liposomes. Zhao YN; Cao YN; Sun J; Liang Z; Wu Q; Cui SH; Zhi DF; Guo ST; Zhen YH; Zhang SB J Mater Chem B; 2020 Jan; 8(1):27-37. PubMed ID: 31746932 [TBL] [Abstract][Full Text] [Related]
5. Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy. Li J; Guo C; Feng F; Fan A; Dai Y; Li N; Zhao D; Chen X; Lu Y Sci Rep; 2016 Dec; 6():38787. PubMed ID: 27934917 [TBL] [Abstract][Full Text] [Related]
6. Ovarian tumor targeting of docetaxel-loaded liposomes mediated by luteinizing hormone-releasing hormone analogues. In vive distribution in nude mice. Qin Y; Song QG; Zhang ZR; Liu J; Fu Y; He Q; Liu J Arzneimittelforschung; 2008; 58(10):529-34. PubMed ID: 19025064 [TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy. Zhang B; Wang T; Yang S; Xiao Y; Song Y; Zhang N; Garg S J Control Release; 2016 Sep; 238():10-21. PubMed ID: 27432750 [TBL] [Abstract][Full Text] [Related]
8. Biodistribution and Efficacy of Low Temperature-Sensitive Liposome Encapsulated Docetaxel Combined with Mild Hyperthermia in a Mouse Model of Prostate Cancer. Ranjan A; Benjamin CJ; Negussie AH; Chokshi S; Chung PH; Volkin D; Yeram N; Linehan WM; Dreher MR; Pinto PA; Wood BJ Pharm Res; 2016 Oct; 33(10):2459-69. PubMed ID: 27343000 [TBL] [Abstract][Full Text] [Related]
9. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer. Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252 [TBL] [Abstract][Full Text] [Related]
10. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480 [TBL] [Abstract][Full Text] [Related]
11. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells. Eloy JO; Ruiz A; de Lima FT; Petrilli R; Raspantini G; Nogueira KAB; Santos E; de Oliveira CS; Borges JC; Marchetti JM; Al-Jamal WT; Chorilli M Colloids Surf B Biointerfaces; 2020 Oct; 194():111185. PubMed ID: 32574928 [TBL] [Abstract][Full Text] [Related]
13. Docetaxel in combination with metformin enhances antitumour efficacy in metastatic breast carcinoma models: a promising cancer targeting based on PEGylated liposomes. Vakili-Ghartavol R; Mehrabian A; Mirzavi F; Rezayat SM; Mashreghi M; Farhoudi L; Kharrazi S; Sadri K; Jaafari MR J Pharm Pharmacol; 2022 Sep; 74(9):1307-1319. PubMed ID: 35833585 [TBL] [Abstract][Full Text] [Related]
14. Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo. Meng J; Guo F; Xu H; Liang W; Wang C; Yang XD Sci Rep; 2016 Mar; 6():22390. PubMed ID: 26947928 [TBL] [Abstract][Full Text] [Related]
15. Docetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: Drug release, cytotoxicity, and antitumor efficacy. Yoon HY; Kwak SS; Jang MH; Kang MH; Sung SW; Kim CH; Kim SR; Yeom DW; Kang MJ; Choi YW Int J Pharm; 2017 May; 523(1):229-237. PubMed ID: 28341149 [TBL] [Abstract][Full Text] [Related]
16. A novel lipid-based nanomicelle of docetaxel: evaluation of antitumor activity and biodistribution. Ma M; Hao Y; Liu N; Yin Z; Wang L; Liang X; Zhang X Int J Nanomedicine; 2012; 7():3389-98. PubMed ID: 22848167 [TBL] [Abstract][Full Text] [Related]
17. Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy. Hua H; Zhang N; Liu D; Song L; Liu T; Li S; Zhao Y Int J Nanomedicine; 2017; 12():7869-7884. PubMed ID: 29123399 [TBL] [Abstract][Full Text] [Related]
18. Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer. Patel K; Doddapaneni R; Sekar V; Chowdhury N; Singh M Mol Pharm; 2016 Jun; 13(6):2049-58. PubMed ID: 27070720 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/Pharmacodynamic Modeling of Schedule-Dependent Interaction between Docetaxel and Cabozantinib in Human Prostate Cancer Xenograft Models. Chen W; Chen R; Li J; Fu Y; Yang L; Su H; Yao Y; Li L; Zhou T; Lu W J Pharmacol Exp Ther; 2018 Jan; 364(1):13-25. PubMed ID: 29084815 [TBL] [Abstract][Full Text] [Related]
20. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy. Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]